Understanding Nitric Oxide Physiology in the Heart: A Nanomedical Approach
- 1 October 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 96 (7), 13-24
- https://doi.org/10.1016/j.amjcard.2005.07.029
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart FailureNew England Journal of Medicine, 2004
- Race-Specific Differences in Endothelial FunctionCirculation, 2004
- Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in the United States, 1988-2000JAMA, 2003
- Lesser Response to Angiotensin-Converting–Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular DysfunctionNew England Journal of Medicine, 2001
- Race-related differences among patients with left ventricular dysfunction: Observations from a biracial angiographic cohortJournal of Cardiac Failure, 2000
- Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trialsJournal of Cardiac Failure, 1999
- Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid arteryProceedings of the National Academy of Sciences, 1997
- STRUCTURE-FUNCTION ASPECTS IN THE NITRIC OXIDE SYNTHASESAnnual Review of Pharmacology and Toxicology, 1997
- Patterns of comorbidity and mortality risk in blacks and whitesAnnals of Epidemiology, 1996
- Simultaneous Measurements of Ca 2+ and Nitric Oxide in Bradykinin-Stimulated Vascular Endothelial CellsCirculation Research, 1995